Cargando…

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases

Detalles Bibliográficos
Autores principales:	Kim, Ye Seul, Kim, Hyun Ju, Lee, Sanghoon, Park, Young Lip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737820/ https://www.ncbi.nlm.nih.gov/pubmed/26848234 http://dx.doi.org/10.5021/ad.2016.28.1.121

Ejemplares similares

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
por: Saraceno, Rosita, et al.
Publicado: (2013)

Treatment of erythrodermic psoriasis with apremilast
por: Gioe, Olivia A., et al.
Publicado: (2021)

Comparison of the risk of heart failure in psoriasis patients using anti‐TNF α inhibitors and ustekinumab
por: Han, Ju Hee, et al.
Publicado: (2022)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report
por: Valenti, Mario, et al.
Publicado: (2022)

Erythrodermic psoriasis de novo versus skin lesions in chronic lymphocytic leukaemia
por: Słomiak-Wąsik, Anna, et al.
Publicado: (2020)

Acquired Unilateral Nevoid Telangiectasia Accompanied by Liver Metastasis of Colon Cancer
por: Kim, Hyun Ju, et al.
Publicado: (2016)

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo, Yang, et al.
Publicado: (2021)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab
por: Tichy, Martin
Publicado: (2019)

Erythrodermic Psoriasis Following SARS-CoV-2 Infection
por: Fatima-Zahra, A., et al.
Publicado: (2022)

Erythrodermic psoriasis after discontinuation of ixekizumab
por: Potter, Kathryn Anne, et al.
Publicado: (2017)

The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
por: Rao, Suman, et al.
Publicado: (2020)

Organizing Pneumonia Complicated with Erythrodermic Psoriasis
por: Nakamura, Hiroyuki, et al.
Publicado: (2019)

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report
por: Chen, Wenjuan, et al.
Publicado: (2022)

Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
por: Lu, Xujun, et al.
Publicado: (2023)

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
por: Husein-ElAhmed, Husein, et al.
Publicado: (2013)

Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis
por: Trídico, Lívia Arroyo, et al.
Publicado: (2017)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh, Rasnik K, et al.
Publicado: (2016)

Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
por: Noure, Lamya, et al.
Publicado: (2021)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2022)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2021)

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

IgA nephropathy associated with erythrodermic psoriasis: A case report
por: Zhang, Li, et al.
Publicado: (2019)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Okita, Aline Lissa, et al.
Publicado: (2020)

Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
por: Carriero, Martino
Publicado: (2022)

Distributive Shock in Erythrodermic Psoriasis Treated With Norepinephrine and Vasopressin: A Case Report
por: Karimi, Mehrdad, et al.
Publicado: (2023)

Erythrodermic presentation of psoriasis in a patient treated with dupilumab
por: Tracey, Elisabeth H., et al.
Publicado: (2018)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy
por: Ellis, John, et al.
Publicado: (2019)

Erythrodermic psoriasis in post-coronavirus disease 2019 patient
por: Batubara, Irwan Saputra, et al.
Publicado: (2022)

Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
por: Signa, S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hioh8tm3i4pkijfdk8up3mhfhs